CTKB - Cytek Bio Company Long-Term Debts

Graphic logo of Cytek Corp (CTKB)

Cytek Biosciences, Inc. (CTKB) develops unique systems for spectral cell analysis, utilizing proprietary software to outperform laser-based methods. The company's environmental approach is based on chemical recycling and plastic reduction, while current price action reflects the value of 0.02. The business model's revenues rely on the supply of high-tech cytometers to medical centers and pharmaceutical laboratories for immunological research and diagnostics.

CTKB Cytek Biosciences, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Cytek Bio (CTKB)

- price and consensus price forecast:
Share Price cytekbio.com|CTKB - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Cytek Biosciences|CTKB - Total Company Value
- book capitalization data:
Equity per Share Cytek Biosciences|CTKB - Book Capitalization|Market Capitalization to Book Value Ratio cytekbio.com|CTKB - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Cytek Biosciences, Inc.|CTKB - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Cytek Corp|CTKB - Company Debts|Debts to Net Assets Cytek Biosciences|CTKB - Company Long-Term Debts|Short-Term Debt Volume Cytek Biosciences
General company analysis:CTKB (cytekbio.com)
Mass-produced product of Cytek Biosciences

Cytek Biosciences, Inc. (CTKB) incurs high development costs for laser diagnostic systems and cytometry software, necessitating significant external financing. This metric captures total liabilities with maturities exceeding one year, allowing investors to assess debt load risk amid fluctuating interest rates by analyzing the organization's long-term financial debt history to determine the sustainability of the business model.

Competing companies

Company Long-Term Indebtedness agilent.com A|Quest Diagnostics Incorporated - Company Long-Term Debts|ILMN: Company Long-Term Debts|Company Long-Term Debt Cologuard|Revvity Corp (RVTY) - Company Long-Term Indebtedness|BIO (Bio-Rad Laboratories) - Company Long-Term Debts|Company Long-Term Debts NNNN|Company Long-Term Debt Sotera Health (SHC)|Company Long-Term Debt Quidel Corporation QDEL|OPK: Company Long-Term Liabilities|CareDx - Long-Term Debt|Company Long-Term Debt MRVI (Maravai LifeSciences)|FLGT - Long-Term Debt Volume|Standard BioTools - Company Long-Term Debts|OSUR (OraSure Technologies, Inc.) - Long-Term Debt Volume|XGN: Company Long-Term Debt|Long-Term Debt Volume MDxHealth, Inc.|Company Long-Term Debts LUCD (Lucid Diagnostics Inc.)|Company Long-Term Liabilities prenetics.com PRE|IMDX: Company Long-Term Liabilities|TRIB - Long-Term Debt|Company Long-Term Liabilities ProPhase PRPH|AIMD - Amount of Long-Term Liabilities|Company Long-Term Debts CODX|HSCS (heartsciences.com) - Long-Term Debt|BMRA (Biomerica) - Company Long-Term Debt|Company Long-Term Debts Cardio Diagnostics Holdings, Inc. (CDIO)|Virax Biolabs Group Ltd (VRAX) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Bluejay Diagnostics Corp (BJDX)|Company Long-Term Debts Aspira Women's Health AWH|Company Long-Term Debt acceleratediagnostics.com AXDX|Company Long-Term Debts CNTG (CENTOGENE)|ENZ: Long-Term Debt Volume|Company Long-Term Debt FRES|GENE (Genetic Technologies Limited) - Long-Term Debt|ME: Company Long-Term Debt|Long-Term Debt Volume psychemedics.com